244 related articles for article (PubMed ID: 30478673)
1. Early Skeletal Muscle Loss in Non-Small Cell Lung Cancer Patients Receiving Chemoradiation and Relationship to Survival.
Kiss N; Beraldo J; Everitt S
Support Care Cancer; 2019 Jul; 27(7):2657-2664. PubMed ID: 30478673
[TBL] [Abstract][Full Text] [Related]
2. Skeletal muscle radiodensity is prognostic for survival in patients with advanced non-small cell lung cancer.
Sjøblom B; Grønberg BH; Wentzel-Larsen T; Baracos VE; Hjermstad MJ; Aass N; Bremnes RM; Fløtten Ø; Bye A; Jordhøy M
Clin Nutr; 2016 Dec; 35(6):1386-1393. PubMed ID: 27102408
[TBL] [Abstract][Full Text] [Related]
3. Predictive value of skeletal muscle mass for immunotherapy with nivolumab in non-small cell lung cancer patients: A "hypothesis-generator" preliminary report.
Cortellini A; Verna L; Porzio G; Bozzetti F; Palumbo P; Masciocchi C; Cannita K; Parisi A; Brocco D; Tinari N; Ficorella C
Thorac Cancer; 2019 Feb; 10(2):347-351. PubMed ID: 30600905
[TBL] [Abstract][Full Text] [Related]
4. Influence of conformal radiotherapy technique on survival after chemoradiotherapy for patients with stage III non-small cell lung cancer in the National Cancer Data Base.
Sher DJ; Koshy M; Liptay MJ; Fidler MJ
Cancer; 2014 Jul; 120(13):2060-8. PubMed ID: 24692108
[TBL] [Abstract][Full Text] [Related]
5. Update of a Prospective Study of Stereotactic Body Radiation Therapy for Post-Chemoradiation Residual Disease in Stage II/III Non-Small Cell Lung Cancer.
Kumar S; Feddock J; Li X; Shearer AJ; Hall L; Shelton BJ; Arnold S; McGarry RC
Int J Radiat Oncol Biol Phys; 2017 Nov; 99(3):652-659. PubMed ID: 29280459
[TBL] [Abstract][Full Text] [Related]
6. Neoadjuvant chemoradiation and surgery improves survival outcomes compared with definitive chemoradiation in the treatment of stage IIIA N2 non-small-cell lung cancer.
Darling GE; Li F; Patsios D; Massey C; Wallis AG; Coate L; Keshavjee S; Pierre A; De Perrot M; Yasufuku K; Cypel M; Waddell T
Eur J Cardiothorac Surg; 2015 Nov; 48(5):684-90; discussion 690. PubMed ID: 25567960
[TBL] [Abstract][Full Text] [Related]
7. Impact of pre-treatment C-reactive protein level and skeletal muscle mass on outcomes after stereotactic body radiotherapy for T1N0M0 non-small cell lung cancer: a supplementary analysis of the Japan Clinical Oncology Group study JCOG0403.
Matsuo Y; Nagata Y; Wakabayashi M; Ishikura S; Onishi H; Kokubo M; Karasawa K; Shioyama Y; Onimaru R; Hiraoka M
J Radiat Res; 2021 Sep; 62(5):901-909. PubMed ID: 34350956
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of sarcopenia and skeletal muscle mass change during preoperative chemoradiotherapy in locally advanced rectal cancer.
Chung E; Lee HS; Cho ES; Park EJ; Baik SH; Lee KY; Kang J
Clin Nutr; 2020 Mar; 39(3):820-828. PubMed ID: 30928250
[TBL] [Abstract][Full Text] [Related]
9. Imaging skeletal muscle volume, density, and FDG uptake before and after induction therapy for non-small cell lung cancer.
Goncalves MD; Taylor S; Halpenny DF; Schwitzer E; Gandelman S; Jackson J; Lukose A; Plodkowski AJ; Tan KS; Dunphy M; Jones LW; Downey RJ
Clin Radiol; 2018 May; 73(5):505.e1-505.e8. PubMed ID: 29317048
[TBL] [Abstract][Full Text] [Related]
10. Trimodality therapy for stage IIIA non-small cell lung cancer: benchmarking multi-disciplinary team decision-making and function.
Dickhoff C; Hartemink KJ; van de Ven PM; van Reij EJ; Senan S; Paul MA; Smit EF; Dahele M
Lung Cancer; 2014 Aug; 85(2):218-23. PubMed ID: 24976333
[TBL] [Abstract][Full Text] [Related]
11. Enhancing evaluation of sarcopenia in patients with non-small cell lung cancer (NSCLC) by assessing skeletal muscle index (SMI) at the first lumbar (L1) level on routine chest computed tomography (CT).
Recio-Boiles A; Galeas JN; Goldwasser B; Sanchez K; Man LMW; Gentzler RD; Gildersleeve J; Hollen PJ; Gralla RJ
Support Care Cancer; 2018 Jul; 26(7):2353-2359. PubMed ID: 29417293
[TBL] [Abstract][Full Text] [Related]
12. Sarcopenia is associated with poor prognosis after chemoradiotherapy in patients with stage III non-small-cell lung cancer: a retrospective analysis.
Katsui K; Ogata T; Sugiyama S; Yoshio K; Kuroda M; Hiraki T; Kiura K; Maeda Y; Toyooka S; Kanazawa S
Sci Rep; 2021 Jun; 11(1):11882. PubMed ID: 34088965
[TBL] [Abstract][Full Text] [Related]
13. Severe muscle loss during radical chemoradiotherapy for non-metastatic nasopharyngeal carcinoma predicts poor survival.
Huang X; Ma J; Li L; Zhu XD
Cancer Med; 2019 Nov; 8(15):6604-6613. PubMed ID: 31517443
[TBL] [Abstract][Full Text] [Related]
14. Relationship Between Preoperative Sarcopenia Status and Immuno-nutritional Parameters in Patients with Early-stage Non-small Cell Lung Cancer.
Shoji F; Matsubara T; Kozuma Y; Haratake N; Akamine T; Takamori S; Katsura M; Toyokawa G; Okamoto T; Maehara Y
Anticancer Res; 2017 Dec; 37(12):6997-7003. PubMed ID: 29187486
[TBL] [Abstract][Full Text] [Related]
15. Increased adipose tissue is associated with improved overall survival, independent of skeletal muscle mass in non-small cell lung cancer.
Tao J; Fang J; Chen L; Liang C; Chen B; Wang Z; Wu Y; Zhang J
J Cachexia Sarcopenia Muscle; 2023 Dec; 14(6):2591-2601. PubMed ID: 37724690
[TBL] [Abstract][Full Text] [Related]
16. Patient-reported lung symptoms as an early signal of impending radiation pneumonitis in patients with non-small cell lung cancer treated with chemoradiation: an observational study.
Yue J; Shi Q; Xu T; Jeter M; Chen TY; Komaki R; Gomez DR; Pan T; Cleeland CS; Liao Z; Wang XS
Qual Life Res; 2018 Jun; 27(6):1563-1570. PubMed ID: 29549533
[TBL] [Abstract][Full Text] [Related]
17. Clinical Impact and Risk Factors for Skeletal Muscle Loss After Complete Resection of Early Non-small Cell Lung Cancer.
Takamori S; Toyokawa G; Okamoto T; Shimokawa M; Kinoshita F; Kozuma Y; Matsubara T; Haratake N; Akamine T; Takada K; Katsura M; Hirai F; Shoji F; Tagawa T; Oda Y; Honda H; Maehara Y
Ann Surg Oncol; 2018 May; 25(5):1229-1236. PubMed ID: 29327178
[TBL] [Abstract][Full Text] [Related]
18. Definitive chemotherapy and radiotherapy in patients with stage II non-small cell lung cancer: A population-based outcomes study.
Sampath S; Hall M; Schultheiss TE
Lung Cancer; 2015 Oct; 90(1):61-4. PubMed ID: 26231092
[TBL] [Abstract][Full Text] [Related]
19. Reduction in Tumor Volume by Cone Beam Computed Tomography Predicts Overall Survival in Non-Small Cell Lung Cancer Treated With Chemoradiation Therapy.
Jabbour SK; Kim S; Haider SA; Xu X; Wu A; Surakanti S; Aisner J; Langenfeld J; Yue NJ; Haffty BG; Zou W
Int J Radiat Oncol Biol Phys; 2015 Jul; 92(3):627-33. PubMed ID: 26068495
[TBL] [Abstract][Full Text] [Related]
20. Prognostic impact of cancer cachexia in patients with advanced non-small cell lung cancer.
Kimura M; Naito T; Kenmotsu H; Taira T; Wakuda K; Oyakawa T; Hisamatsu Y; Tokito T; Imai H; Akamatsu H; Ono A; Kaira K; Murakami H; Endo M; Mori K; Takahashi T; Yamamoto N
Support Care Cancer; 2015 Jun; 23(6):1699-708. PubMed ID: 25430482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
